Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.66 |
| ▸ | ESR1 | P03372 | 2/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.66 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.66 |
| ▸ | KDR | P35968 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.55 |
| ▸ | STAT1 | P42224 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propylparaben SCHEMBL28219717 | 0.94 | ESR1 (0.78) | LMNAALDH1A1TDP1ESR1TSHR | |
| SCHEMBL28881217 | 0.93 | ALDH1A1 (0.75) | LMNAALDH1A1TDP1ESR1TSHR | |
| SCHEMBL12832705 | 0.90 | TSHR (0.68) | LMNAALDH1A1TDP1ESR1TSHR | |
| SCHEMBL7181498 | 0.89 | LMNA (1.00) | LMNAALDH1A1TDP1ESR1TSHR | |
| SCHEMBL130761 | 0.89 | LMNA (1.00) | LMNAALDH1A1TDP1ESR1TSHR | |
| SCHEMBL13291921 | 0.88 | CNR2 (0.68) | LMNAALDH1A1TDP1ESR1TSHR | |
| SCHEMBL28387455 | 0.87 | LMNA (0.96) | LMNAALDH1A1TDP1ESR1TSHR | |
| Methane SCHEMBL28760616 | 0.87 | LMNA (0.96) | LMNAALDH1A1TDP1ESR1TSHR | |
| SCHEMBL4465574 | 0.87 | LMNA (0.96) | LMNAALDH1A1TDP1ESR1TSHR | |
| SCHEMBL30886680 | 0.87 | LMNA (0.96) | LMNAALDH1A1TDP1ESR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2297162-A1 | COMPOUNDS | Amura Therapeutics Limited (GB) | 2011-03-23 | — | — | EP | claimed |
| WO-2009144450-A1 | TETRAHYDROFURO [3, 2-B] PYRROL-3-ONE DERIVATIVES AS INHIBITORS OF CYSTEINE PROTEASES | AMURA THERAPEUTICS LIMITED (GB) | 2009-12-03 | — | — | WO | claimed |
| WO-2009112839-A1 | COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2009-09-17 | — | — | WO | claimed |
| EP-2081919-A1 | TETRAHYDROFURO [3, 2-B]PYRR0L-3-0NE INTERMEDIATES | Amura Therapeutics Limited (GB) | 2009-07-29 | — | — | EP | claimed |
| WO-2008007132-A1 | TETRAHYDROFURO [3, 2-B] PYRR0L-3-0NE INTERMEDIATES | AMURA THERAPEUTICS LIMITED (GB) | 2008-01-17 | — | — | WO | claimed |
| EP-4274564-A1 | NIMBOLIDE ANALOGS AND METHODS OF USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-11-15 | — | — | EP | disclosed |
| WO-2023212746-A2 | A UNIFIED STRATEGY FOR THE TOTAL SYNTHESES OF ERIBULIN AND A MACROLACTAM ANALOGUE OF HALICHONDRIN B | WILLIAM MARSH RICE UNIVERSITY (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023164777-A1 | GUCY2C-TARGETED RADIOPHARMACEUTICALS AND USE THEREOF | Fusion Pharmaceuticals Inc. (CA) | 2023-09-07 | — | — | WO | disclosed |
| WO-2022150667-A1 | NIMBOLIDE ANALOGS AND METHODS OF USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-07-14 | — | — | WO | disclosed |
| EP-3794009-A1 | BIARYL AMIDES WITH MODIFIED SUGAR GROUPS FOR TREATMENT OF DISEASES ASSOCIATED WITH HEAT SHOCK PROTEIN PATHWAY | Reata Pharmaceuticals, Inc. (US) | 2021-03-24 | — | — | EP | disclosed |
| EP-3740479-A1 | DNA-PK INHIBITORS | Vertex Pharmaceuticals Incorporated (US) | 2020-11-25 | — | — | EP | disclosed |
| WO-2020227180-A1 | SULFUR AND AMIDE TROPOLONE INHIBITORS OF NUCLEOTIDYL TRANSFERASES AND USES THEREFOR | SAINT LOUIS UNIVERSITY (US) | 2020-11-12 | — | — | WO | disclosed |
| WO-1997030051-A1 | ACYCLIC NUCLEOSIDE DERIVATIVES | MEDIVIR AB (SE) | 1997-08-21 | — | — | WO | disclosed |
| EP-0773926-A1 | DIFLUOROSTATONE ANTIVIRAL AGENTS | MERRELL PHARMACEUTICALS INC. (US) | 1997-05-21 | — | — | EP | disclosed |
| EP-0717731-A1 | DIFLUORO STATONE ANTIVIRAL ANALOGS | MERRELL PHARMACEUTICALS INC. (US) | 1996-06-26 | — | — | EP | disclosed |
| EP-0702696-A1 | TRIFUNCTIONAL ANTITHROMBIN AND ANTIPLATELET PEPTIDES | MERRELL PHARMACEUTICALS INC. (US) | 1996-03-27 | — | — | EP | disclosed |
| EP-0648224-A1 | CONFORMATIONALLY RESTRAINED PEPTIDE ANALOGS AS ANTIPLATELET AGENTS | MERRELL PHARMACEUTICALS INC. (US) | 1995-04-19 | — | — | EP | disclosed |
| WO-1994029349-A1 | TRIFUNCTIONAL ANTITHROMBIN AND ANTIPLATELET PEPTIDES | MERRELL PHARMACEUTICALS INC. (US) | 1994-12-22 | — | — | WO | disclosed |
| EP-0540574-A4 | — | — | 1994-04-27 | — | — | EP | disclosed |
| EP-0540574-A1 | ANTICOAGULANT PEPTIDES. | MERRELL DOW PHARMA (US) | 1993-05-12 | — | — | EP | disclosed |